Kontakt
GBG Forschungs GmbH
Martin-Behaim-Straße 12
63263 Neu-Isenburg
Tel.: +49610274800
Fax: +4961027480440
E-Mail: Infgbgd
Kontaktformular
News
04.06.2018 ASCO: GeparNuevo Presentation
GeparNuevo Results of primary objective were presented at ASCO 2018: Durvalumab increases the pCR rate in TNBC patients.
Mehr ...22.01.2018 JCO top-cited
Our Paper about PIK3CA-Mutations is one of the most-cited papers in JCO.
Mehr ...17.08.2017 Effect of BRCA1/2 Status on Response to Neoadjuvant Carboplatin in TNBC
Our paper on mutations analysis in the Geparsixto TNBC-Arm was discussed at ASCO-News.
Mehr ...05.07.2017 PALOMA-3 Results published
Palbociclib Combined with Fulvestrant in PremenopausalWomen with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results
Mehr ...
GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440